[Journal logo]

Volume 64 
Part 3 
Page o635  
March 2008  

Received 1 February 2008
Accepted 25 February 2008
Online 27 February 2008

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.003 Å
R = 0.043
wR = 0.128
Data-to-parameter ratio = 13.8
Details
Open access

4-Chloro-2-[(E)-({4-[N-(3,4-dimethylisoxazol-5-yl)sulfamoyl]phenyl}iminio)methyl]phenolate

aDepartment of Chemistry, Bahauddin Zakariya University, Multan 60800, Pakistan,bUniversity of Sargodha, Department of Physics, Sargodha, Pakistan, and cGovernment College University, Department of Chemistry, Lahore, Pakistan
Correspondence e-mail: dmntahir_uos@yahoo.com

The title compound, C18H16ClN3O4S, is a Schiff base ligand in which the H atom of the hydroxy group has moved to the N atom of the imine group, resulting in a zwitterion. The structure is stabilized by an intramolecular (N-H...O) and five intermolecular (C-H...O, C-H...N and N-H...O) hydrogen bonds. The molecules are linked to each other by hydrogen bonds and form a three-dimensional polymeric network. In addition, the aromatic rings are also involved in [pi]-[pi] interactions [centroid-centroid distance between aromatic rings = 3.7525 (11) Å].

Related literature

For related literature, see: Chatterjee et al. (1982[Chatterjee, C., Dattagupta, J. K. & Saha, N. N. (1982). Acta Cryst. B38, 1845-1847.]); Chohan et al. (2008[Chohan, Z. H., Shad, H. A., Tahir, M. N. & Khan, I. U. (2008). Acta Cryst. E64 Submitted.]); Hämäläinen et al. (1986[Hämäläinen, R., Lehtinen, M. & Turpeinen, U. (1986). Arch. Pharm. 319, 415-420.]); Nishimori et al. (2005[Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenz, A. & Supuran, C. T. (2005). Bioorg. Med. Chem. Lett. 15, 3828-3833.]).

[Scheme 1]

Experimental

Crystal data
  • C18H16ClN3O4S

  • Mr = 405.85

  • Monoclinic, P 21 /n

  • a = 15.1871 (6) Å

  • b = 7.2555 (3) Å

  • c = 16.6267 (7) Å

  • [beta] = 94.081 (2)°

  • V = 1827.45 (13) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.35 mm-1

  • T = 296 (2) K

  • 0.30 × 0.25 × 0.20 mm

Data collection
  • Bruker Kappa APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2005[Bruker (2005). SADABS. Bruker AXS Inc. Madison, Wisconsion, USA.]) Tmin = 0.886, Tmax = 0.935

  • 18429 measured reflections

  • 4669 independent reflections

  • 3443 reflections with I > 2[sigma](I)

  • Rint = 0.028

Refinement
  • R[F2 > 2[sigma](F2)] = 0.042

  • wR(F2) = 0.127

  • S = 1.04

  • 3443 reflections

  • 250 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.38 e Å-3

  • [Delta][rho]min = -0.23 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N1-H1...O1 0.87 (2) 1.85 (2) 2.574 (2) 140 (2)
C7-H7...N3i 0.93 2.54 3.429 (3) 161
C12-H12...O2i 0.93 2.59 3.391 (3) 145
C17-H17C...O3ii 0.96 2.57 3.516 (3) 168
C17-H17B...O1iii 0.96 2.38 3.276 (3) 156
N2-H2...O1iii 0.79 (2) 2.06 (2) 2.846 (2) 173 (2)
Symmetry codes: (i) [-x+{\script{3\over 2}}, y-{\script{1\over 2}}, -z+{\script{1\over 2}}]; (ii) x, y-1, z; (iii) -x+1, -y+1, -z+1.

Data collection: APEX2 (Bruker, 2007[Bruker (2007). APEX2 and SAINT. Bruker AXS Inc. Madison, Wisconsion, USA.]); cell refinement: APEX2; data reduction: SAINT (Bruker, 2007[Bruker (2007). APEX2 and SAINT. Bruker AXS Inc. Madison, Wisconsion, USA.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]) and PLATON (Spek, 2003[Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.]); software used to prepare material for publication: WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]) and PLATON.


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: PV2068 ).


Acknowledgements

The authors acknowledge the Higher Education Commission, Islamabad, Pakistan, for funding the purchase of the diffractometer.

References

Bruker (2005). SADABS. Bruker AXS Inc. Madison, Wisconsion, USA.
Bruker (2007). APEX2 and SAINT. Bruker AXS Inc. Madison, Wisconsion, USA.
Chatterjee, C., Dattagupta, J. K. & Saha, N. N. (1982). Acta Cryst. B38, 1845-1847.  [CrossRef] [ISI] [details]
Chohan, Z. H., Shad, H. A., Tahir, M. N. & Khan, I. U. (2008). Acta Cryst. E64 Submitted. [details]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [ChemPort] [details]
Hämäläinen, R., Lehtinen, M. & Turpeinen, U. (1986). Arch. Pharm. 319, 415-420.
Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenz, A. & Supuran, C. T. (2005). Bioorg. Med. Chem. Lett. 15, 3828-3833.  [CrossRef] [PubMed] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2003). J. Appl. Cryst. 36, 7-13.  [ISI] [CrossRef] [ChemPort] [details]


Acta Cryst (2008). E64, o635  [ doi:10.1107/S1600536808005321 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.